AHIP's focus on issues like food, housing and transportation—factors experts say have a profound impact on a patient's health—showed insurers are beginning to pay attention to what happens outside of the hospital, even if returns are still hard to measure.
Eighty percent of nearly 750 providers, payers and pharmaceutical companies polled said they are optimistic that the new health system-led generic-drug company will change the status quo, and 90% said they would buy drugs from it, according to a new survey.
A small but growing cadre of executives are taking the patient experience to the next level, and linking satisfaction with quality and safety.
Intermountain Healthcare recently announced a joint venture with home healthcare company Lifesprk to provide seniors with nonclinical support services.
McKay-Dee Hospital in April 2017 opened a center specifically for patients experiencing a mental health crisis.
Intermountain Healthcare announced it will outsource 98 information technology jobs to DXC Technology, which will continue their employment for at least one year.
Salt Lake City-based Intermountain Healthcare will outsource 2,300 nonclinical employees to revenue-cycle management company R1 RCM, a move that is expected to save the integrated health system $70 million over the next three years.
Hospitals have long been bedeviled by shortages and price spikes for the generic drugs that are essential to their day-to-day operations.
Salt Lake City-based Intermountain Healthcare will outsource 2,300 non clinical employees to revenue cycle management company R1 RCM, a move that is expected to save the integrated health system $70 million over the next three years.
The new health system-led generic-drug company sent a shockwave through the healthcare industry, but experts warned that it would take plenty of time and capital to ultimately lower drug prices and mitigate shortages.
As four not-for-profit health systems unveiled plans to create their own generic-drug company, experts say they'll face an uphill battle to make a significant dent in rising drug prices and shortages.
Organizations like Humana and Intermountain Healthcare are using existing assessment tools to gauge success of nonmedical health.